Skip to main content

User account menu

  • Log in
X

Main navigation

  • Specialties
    • Alzheimer Disease
    • Behavioral Neurology
    • Migraine
    • Multiple Sclerosis
    • Neuroimmunology
    • Neuromuscular Disorders
    • Pain Medicine
    • Parkinson Disease
    • Seizures
    • Sleep Medicine
    • Spinal Disorders
    • Stroke & Vascular
    • Traumatic Brain Injury
  • Resources
    • News
    • Expert Insights
    • Interactive Features
    • Interviews
    • Neurology Advances
    • Partner Spotlight
    • Podcasts
    • Videos
  • Excellence Forums
    • Alzheimer Disease
    • Behavioral Neurology
    • Migraine
    • Multiple Sclerosis
    • Pain Medicine
    • Parkinson Disease
    • Seizures
    • Sleep Medicine
    • Stroke & Vascular
    • Traumatic Brain Injury
  • Meetings
    • AAN Annual Meeting
    • AAN Sports Concussion Conference
    • AES Annual Meeting
    • AHS Annual Scientific Meeting
    • ANA Annual Meeting
    • APSS SLEEP 2020
    • Alzheimer's Association International Conference
    • CMSC Annual Meeting
    • ECTRIMS/ACTRIMS Joint Triennial Meeting
    • MDS Congress
  • CME
    • Migraine 360
    • Program Listing
  • About
    • Contact Us
    • Editorial Advisory Board
    • Editorial Description
  • Neurology Week
  • Search
Search Search
Featured
Expert Conversations: Cerebral Amyloid Angiopathy
In this podcast, Neurology Learning Network's Alzheimer Disease Section Editor Daniel Claassen, MD, interviews Matthew Schrag, MD, PhD, about the pathophysiology of cerebral amyloid angiopathy (CAA), clinical presentations of CAA that may mimic other conditions, and more.
Systematic Review Cautions Promoting White Noise Machines as a Viable Sleep Aid
Page B. Pennell, MD, on Changes in Antiepileptic Drug Dose and Seizure Frequency Among Pregnant Women With Epilepsy
Controversial Alzheimer Disease Drug Aducanumab Is Approaching a Decision From the FDA: Here’s What You Need to Know
Expert Conversations: A Review of Data for Thrombolysis
Pharmacologic Management of Migraine in the ED: Opioid Use Decreased From 2010 to 2017
Expert Conversations: Networks of Memory and Alzheimer Disease
Jeffrey Huang, PhD, Talks Remyelination Strategies in Multiple Sclerosis
The Neurologist Is In, Ep. 4: Palliative Care and Challenging Conversations With Patients and Families

News

Second Intravenous Immunoglobulin Dose Not Suggested for Severe Guillain-Barré Syndrome
Ponesimod More Effective than Teriflunomide at Treating Relapsing Multiple Sclerosis
FDA Approves Ponesimod for Adults With Relapsing Multiple Sclerosis
Gene Therapy Improves Survival for Infantile Spinal Muscular Atrophy
Endovascular Therapy after Stroke Improved Quality of Life Outcomes for Patients
Donanemab Yields Reduced Cognitive Decline in Early Alzheimer’s Disease
View More

Excellence Forums

Alzheimer Disease
Migraine
Multiple Sclerosis
Sleep Medicine
Stroke & Vascular

Newsrooms

Partner Spotlight
Alzheimer’s Association International Conference
APSS SLEEP 2020
ECTRIMS/ACTRIMS Joint Triennial Meeting
ANA Annual Meeting

Continuing Education

Migraine 360
Migraine360: Translating a Novel Treatment Paradigm to Real-World Clinical Practice
Migraine Prevention: New Opportunities for Pain Relief
Stay in the know.
NLN Newsletter

CONNECT

  • Facebook
  • Twitter
  • Linkedin

ABOUT

Footer

  • About Us
  • Contact Us
  • Privacy Policy

VISIT OUR OTHER BRANDS

Footer Brands

  • Migraine 360
  • Psychiatry & Behavioral Health Learning Network
© 2021 HMP. Rx Summit is a trademark of HMP. All Rights Reserved.